Despite recommended guidelines, many women who received chest radiation for a childhood cancer have not had mammography screening for breast cancer in the past 2 years.
Despite recommended guidelines, a number of women who received chest radiation for a childhood cancer have not had mammography screening for breast cancer in the previous 2 years, according to the results of a study published in the Jan. 28 issue of the Journal of the American Medical Association.
Kevin C. Oeffinger, MD, of the Memorial Sloan-Kettering Cancer Center in New York City, and colleagues, determined the breast cancer surveillance practices among a cohort of women who had childhood cancer treated with chest radiation. A questionnaire was administered to 551 women between June 2005 and August 2006.
The investigators found that 63.5% of the women aged 25 to 39 years and 23.5% of women aged 40 to 50 years had not had a screening mammogram in the previous 2 years. Nearly half (47.3%) of the women under 40 years of age reported never having a mammogram, the researchers report. Age predicted screening mammography; the likelihood of reporting a mammogram nearly doubled for every 5-year increase in age. The strongest predictor for screening mammograms among young women (aged 25 to 39 years) was a physician recommendation, the authors note.
"The risk of breast cancer after exposure to annual low-dose irradiation in the form of x-ray mammography should be explored in future studies as well as the role of MRI as a replacement for x-ray mammography rather than as an adjunctive examination in this group of young women," the authors of an accompanying editorial write.
Oeffinger KC, Ford JS, Moskowitz CS, et al. Breast cancer surveillance practices among women previously treated with chest radiation for a childhood cancer. JAMA. 2009;301:404-414.
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More
Major congenital malformations not linked to first trimester tetracycline use
November 20th 2024A large population-based study found that first-trimester tetracycline exposure does not elevate the risk of major congenital malformations, though specific risks for nervous system and eye anomalies warrant further research.
Read More
No link found between prenatal cannabis use and childhood developmental delay
November 5th 2024In a recent study, offspring of women with cannabis use in early pregnancy confirmed by self-report or toxicology test were not at an increased risk of childhood early developmental delay up to the age of 5.5 years.
Read More
Prenatal cannabis use not linked to offspring ASD development
November 1st 2024In a recent study, adjustments for maternal characteristics mediated the association between maternal prenatal cannabis use and offspring autism spectrum disorder, indicating no statistically significant increase in risk.
Read More
Importance of reproductive health services for adolescents during the COVID-19 pandemic
October 30th 2024In a recent study, high rates of reproductive health service use were reported among adolescent mothers, indicating the benefits of this model for providing care when other options are unavailable.
Read More